Folotyn

Active Ingredient(s): Pralatrexate
FDA Approved: * September 24, 2009
Pharm Company: * ALLOS THERAPEUTICS, INC
Category: Cancer

Pralatrexate, sold under the brand name Folotyn, is a medication used for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL).[1][2] Pralatrexate was approved for medical use in the United States in September 2009, as the first treatment for Peripheral T-cell Lymphoma (PTCL), an often aggressive type of non-Hodgkins lymphoma.[2][3] Contents 1 Medical uses 2 Mechanism 3 Discovery 4 Society and culture 4.1... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Folotyn 20 mg/ml Intravenous Injection
NDC: 48818-001
Labeler:
Allos Therapeutics
Folotyn 20 mg/ml Intravenous Injection
NDC: 72893-003
Labeler:
Acrotech Biopharma LLC
Folotyn 40 mg/2ml Intravenous Injection
NDC: 72893-005
Labeler:
Acrotech Biopharma LLC

Popular Topics

Folotyn

Wanting seek out for more information re: Folotyn, my dad will begin using this drug soon and I want to educate myself. ...